Immune Dysfunction as Measured by the Systemic Immune-Inflammation Index is Associated with the Sub-Type of Minimal Residual Disease and Outcome in Stage II Colon Cancer Treated wi...

por Murray, Nigel P, Villalon, Ricardo, Orrego, Shenda, Guzman, Eghon
Publicado 2021

Improvement in the Neutrophil-Lymphocyte Ratio after Combined Fluorouracil, Leucovorina and Oxaliplatino based (FOLFOX) Chemotherapy for Stage III Colon Cancer is Associated with I...

por Murray, Nigel P, Villalon, Ricardo, Hartmann, Dan, Rodriguez, Patricia Maria, Aedo, Socrates
Publicado 2022

Subtypes of minimal residual disease and outcome for stage II colon cancer treated by surgery alone

por Murray, Nigel P, Aedo, Socrates, Villalon, Ricardo, Albarran, Vidal, Orrego, Shenda, Guzman, Eghon
Publicado 2020

Effect of FOLFOX on minimal residual disease in Stage III colon cancer and risk of relapse

por Murray, Nigel P, Aedo, Sócrates, Villalon, Ricardo, López, Marco Antonio, Minzer, Simona, Muñoz, Lorena, Orrego, Shenda, Contreras, Luis, Arzeno, Lucas, Guzman, Eghon
Publicado 2019